Status:
COMPLETED
Serum 25-hydroxy Vitamin D [25(OH)D] Levels, Supplemental Vitamin D, and Parathyroid Hormone Levels in Premature Infants
Lead Sponsor:
University of Nebraska
Conditions:
Premature Infants
Eligibility:
All Genders
23-32 years
Phase:
NA
Brief Summary
This study will determine levels of vitamin D supplementation to achieve goal serum 25-hydroxy vitamin D \[25(OH)D\] levels of 30 ng/mL, and to define serum 25(OH)D levels required to achieve suppress...
Detailed Description
The specific aims of this study are to determine levels of vitamin D supplementation to achieve goal serum 25(OH)D levels of 30 ng/mL, and to define serum 25(OH)D levels required to achieve suppressio...
Eligibility Criteria
Inclusion
- NICU hospitalized infants
- 23-32 weeks gestation
Exclusion
- congential anomalies
- disorders of calcium metabolism
- inborn error of metabolism
- kidney disease
- liver disease
- use of steroids
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT01469650
Start Date
January 1 2012
End Date
July 1 2013
Last Update
September 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unversity of Nebraska Medical Center
Omaha, Nebraska, United States, 68198